Mayilvahanan Shanmugam

Mayilvahanan (Mayil) Shanmugam has conducted research in Molecular Genetics and Microbiology for more than three decades.​

Always inspiring the research team with his can-do attitude and scientific rigor, Dr. Shanmugam leads the research and development work in the areas of microbiology and molecular genetics. He most recently led the presentation at the American Molecular Pathology conference on “Clinical Evaluation of a Robust Custom-Designed Multiplexed qPCR Microarray for Urinary Tract Infections” and has managed a pipeline of research for Acutis.

Dr. Shanmugam has extensively researched topics such as the pathogenic trait identification of bacteria and its genetic modifications, DNA and RNA sequence analysis, new peptide therapeutic molecules for possible cancer therapeutics, transposon mutagenesis for microbial gene characterization using Next-Generation Sequencing. He was conferred a Co-Principal Investigator – NIH Exploratory/Developmental Research Grant Award (R21) 2018-2020.